Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
36.4%
% of PJP's 22 holdings also in MEDX
26.7%
% of MEDX's 30 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 6.3% | 6.1% | 6.1% |
|
ELI LILLY & CO | 5.8% | 15.1% | 5.8% |
|
ABBVIE INC | 5.2% | 7.3% | 5.2% |
|
MERCK & CO. INC. | 5.8% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 5.4% | 4.5% | 4.5% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to MEDX
|
GERON CORP | 6.9% |
|
ABBOTT LABORATORIES | 5.1% |
|
UNITED THERAPEUTICS CORP | 4.4% |
|
LIGAND PHARMACEUTICALS-CL B | 4.3% |
|
CORCEPT THERAPEUTICS INC | 4.3% |
|
BIOSANTE PHARMACEUTICALS INC | 4.1% |
|
SUPERNUS PHARMACEUTICALS INC | 3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 3.6% |
|
INNOVIVA, INC. | 3.5% |
|
PACIRA PHARMACEUTICALS INC | 3.5% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -9.3% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
BRISTOL-MYERS SQUIBB CO | -4.7% |
 |
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.9% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
INTELLIA THERAPEUTICS, INC. | -2.1% |